Navigation Links
Cardinal Rigali Criticizes Draft NIH Guidelines for Destructive Stem Cell Research

For first time, federal tax dollars will be used to encourage destruction of living embryonic human beings

"Suffering patients and their families deserve better," says Cardinal Rigali

WASHINGTON, April 21 /PRNewswire-USNewswire/ -- Cardinal Justin Rigali, Chairman of the U.S. Catholic bishops' Committee on Pro-Life Activities, reacted today to new draft guidelines for human embryonic stem cell research issued late last week by the National Institutes of Health. The text of his statement follows:

New draft guidelines for federally funded stem cell research involving the destruction of human embryos, released Friday by the National Institutes of Health, mark a new chapter in divorcing biomedical research from its necessary ethical foundation. Without unconditional respect for the life of each and every member of the human race, research involving human subjects does not represent true progress. It becomes another way for some human beings to use and mistreat others for their own goals. Suffering patients and their families deserve better, through increased support for promising and ethically sound stem cell research and treatments that harm no one.

In most respects these draft guidelines reflect the policy approved but never implemented by the Clinton administration in 2000. However, the Clinton policy was limited to embryos that had been frozen, to ensure that parents had time to consider the decision to donate them for research; the new guidelines are broader in allowing destruction of newly created embryos that were never frozen, increasing the prospects for a rushed and biased consent process.

Despite supporters' constant claim that this agenda involves only embryos that "would otherwise be discarded," the guidelines provide that the option of donating embryonic children for destructive research will be offered to parents alongside all other options, including those allowing the embryos to live. For the first time, federal tax dollars will be used to encourage destruction of living embryonic human beings for stem cell research -- including human beings who otherwise would have survived and been born.

It is noteworthy that, despite calls for an even broader policy by some in Congress and the research community, the draft guidelines do not allow federally funded stem cell research using embryos specially created for research purposes by in vitro fertilization or cloning. We can hope that the NIH and Congress will continue to respect this ethical norm, and will realize that the alleged "need" for violating it is more implausible than ever due to advances in reprogramming adult cells to act like embryonic stem cells. However, congressional supporters of destructive human embryo research have already said they will pursue a more extreme policy. The Catholic bishops of the United States will be writing to Congress and the Administration about the need to restore and maintain barriers against the mistreatment of human life in the name of science, and we urge other concerned citizens to do the same.

SOURCE U.S. Conference of Catholic Bishops, Secretariat for Pro-Life Activities
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
2. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
3. Cardinal Health To Announce First-Quarter Results on November 5
4. Cardinal Health Announces Sector Management Change
5. Cardinal Health Reports First Quarter Results
6. Cardinal Health, Sentry Data Systems Introduce New Technology to Help Health Care Providers More Cost-Efficiently Care for Underserved
7. Cardinal Health Receives DEA Order to Temporarily Cease Distribution of Controlled Substances from Auburn, Wash. Facility
8. Cardinal Health Foundation Grants $537,000 to Rural, Public Hospitals in Support of IHIS 5 Million Lives Campaign
9. Cardinal Health to Cease Distribution of Controlled Substances from Florida Facility
10. Cardinal Health to Announce Second-Quarter Results on January 29
11. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector
Post Your Comments:
(Date:11/27/2015)... ... ... There is only one major question facing all law firms in the 21st ... not been an easy question to answer. Especially when the senior partners and lawyers ... share the same discipline around working long hours. , In addition to this ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... According to ... out by the University of Toronto and the University of British Columbia suggested that ... for head injuries. The article explains that part of the reason for the controversial ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... the health care in America. As people age, more care is needed, especially ... are rising, and medical professionals are being overworked. The forgotten part of this ...
(Date:11/27/2015)... PA (PRWEB) , ... November 27, 2015 , ... ... be a safe and convenient way to dispense prescription medications at home, so ... and effective way to monitor and dispense prescription medications. In doing so, it ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced a special ... 10% off of their purchase of lice treatment product. In addition, customers will receive ... a company spokesperson. “Finding lice is a sure way to ruin the holidays, so ...
Breaking Medicine News(10 mins):
(Date:11/29/2015)... Nov. 29, 2015  The GE Health Cloud 1 ... Society of North America (RSNA) meeting ... healthcare industry, the new cloud ecosystem and its applications will ... care pathways and multidisciplinary teams – both inside and outside ... and CEO of GE. "As the digital industrial leader, we ...
(Date:11/27/2015)... , Pays-Bas, November 27, 2015 ... au traitement photodynamique au Bremachlorin contre le cancer ... approche consistant à combiner l,immunothérapie au traitement photodynamique ... --> Une nouvelle approche consistant ... contre le cancer avancé.    ...
(Date:11/27/2015)... 27, 2015  Lannett Company, Inc. (NYSE: ... the acquisition of Kremers Urban Pharmaceuticals Inc. (KU), ... biopharmaceuticals company UCB S.A. (Euronext: UCB). ... acquired KU from UCB for total consideration of ... a customary working capital adjustment, a deduction of ...
Breaking Medicine Technology: